Norton, L. & Massagué, J. Is cancer a disease of self-seeding? Nat. Med. 12, 875–878 (2006).
Kim, M. Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315–1326 (2009).
Bombonati, A. & Sgroi, D. C. The molecular pathology of breast cancer progression. J. Pathol. 223, 307–317 (2011).
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
Png, K. J. et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 25, 226–231 (2011).
Garber, J. E. & Offit, K. Hereditary cancer predisposition syndromes. J. Clin. Oncol. 23, 276–292 (2005).
Boyd, N. F. et al. Heritability of mammographic density, a risk factor for breast cancer. N. Engl. J. Med. 347, 886–894 (2002).
Alowami, S., Troup, S., Al-Haddad, S., Kirkpatrick, I. & Watson, P. H. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 5, R129–R135 (2003).
Milanese, T. R. et al. Age-related lobular involution and risk of breast cancer. J. Natl Cancer Inst. 98, 1600–1607 (2006).
Radisky, D. C. & Hartmann, L. C. Mammary involution and breast cancer risk: transgenic models and clinical studies. J. Mammary Gland Biol. Neoplasia 14, 181–191 (2009).
Ghosh, K. et al. Independent association of lobular involution and mammographic breast density with breast cancer risk. J. Natl Cancer Inst. 102, 1716–1723 (2010).
Halsted, W. S. The results of radical operations for the cure of carcinoma of the breast. Ann. Surg. 46, 1–19 (1907).
Ariel, I. M. Results of treating 1,178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred. J. Surg. Oncol. 12, 137–153 (1979).
Schoppmann, S. F. et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann. Surg. 240, 306–312 (2004).
Shapiro, D. M. & Fugmann, R. A. A role for chemotherapy as an adjunct to surgery. Cancer Res. 17, 1098–1101 (1957).
Fisher, B. Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40 (Suppl.), 574–587 (1977).
Lyman, G. H. et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol. 23, 7703–7720 (2005).
McArthur, H. L. & Hudis, C. A. Breast cancer chemotherapy. Cancer J. 13, 141–147 (2007).
Cox, C. et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann. Surg. Oncol. 13, 708–711 (2006).
Hellman, S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J. Clin. Oncol. 12, 2229–2234 (1994).
Clarke, M. et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366, 2087–2106 (2005).
Holland, R., Veling, S. H., Mravunac, M. & Hendriks, J. H. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56, 979–990 (1985).
Punglia, R. S., Morrow, M., Winer, E. P. & Harris, J. R. Local therapy and survival in breast cancer. N. Engl. J. Med. 356, 2399–2405 (2007).
Giuliano, A. E. et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305, 569–575 (2011).
Dawood, S., Broglio, K., Ensor, J., Hortobagyi, G. N. & Giordano, S. H. Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol. 21, 2169–2174 (2010).
van't Veer, L. J., Paik, S. & Hayes, D. F. Gene expression profiling of breast cancer: a new tumor marker. J. Clin. Oncol. 23, 1631–1635 (2005).
Sotiriou, C. & Pusztai, L. Gene-expression signatures in breast cancer. N. Engl. J. Med. 360, 790–800 (2009).
Liu, H. et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc. Natl Acad. Sci. USA 107, 18115–18120 (2010).
Wicha, M. S., Liu, S. & Dontu, G. Cancer stem cells: an old idea–a paradigm shift. Cancer Res. 66, 1883–1890 (2006).
Norton, L. & Simon, R. Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat. Rep. 61, 1307–1317 (1977).
Gompertz, B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Phil. Trans. Roy. Soc. London 115, 513–583 (1825).
Norton, L. A Gompertzian model of human breast cancer growth. Cancer Res. 48, 7067–7071 (1988).
Norton, L. Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis. 29, 27–36 (2008).
Citron, M. L. et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J. Clin. Oncol. 21, 1431–1439 (2003).
Francis, P. et al. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02–98 randomized trial. J. Natl Cancer Inst. 100, 121–133 (2008).
Held, G., Schubert, J., Reiser, M. & Pfreundschuh, M. Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas. Semin. Hematol. 43, 221–229 (2006).
Tsukamoto, A. S. et al. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55, 619–625 (1988).
Bertucci, F. et al. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res. 64, 8558–8565 (2004).
Smerage, J. B. & Hayes, D. F. The prognostic implications of circulating tumor cells in patients with breast cancer. Cancer Invest. 26, 109–114 (2008).
LaBarge, M. A., Petersen, O. W. & Bissell, M. J. Of microenvironments and mammary stem cells. Stem Cell Rev. 3, 137–146 (2007).
Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
Gocheva, V. et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24, 241–255 (2010).
Jain, R. K. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat. Rev. Cancer 8, 309–316 (2008).
Dang, C., Gilewski, T. A., Surbone, A. & Norton, L. in Holland-Frei Cancer Medicine 6th edn Ch. 43, 645–668 (eds Kufe, D. W. et al., BC Decker, Hamilton, 2003).
Minn, A. J. et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl Acad. Sci. USA 104, 6740–6745 (2007).
Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005–1009 (2009).
Lu, X. et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 23, 1882–1894 (2009).
Norton, L. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. Oncologist 10, 370–381 (2005).
Carmeliet, P, & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).
Rafii, S., Avecilla, S. T. & Jin, D. K. Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display. Cancer Cell 4, 331–333 (2003).
Braakhuis, B. J., Tabor, M. P., Kummer, J. A., Leemans, C. R. & Brakenhoff, R. H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63, 1727–1730 (2003).
Moelans, C. B., de Weger, R. A., Monsuur, H. N., Maes, A. H. & van Diest, P. J. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal. Cell Pathol. (Amst.) 33, 165–173 (2010).
Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11 (2008).
Nguyen, D. X., Bos, P. D. & Massagué, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274–284 (2009).
Zhang, X. H. et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67–78 (2009).
Cenkowski, M. et al. Tumor-to-tumor metastasis: report of a case of renal cell carcinoma metastasizing to a pancreatic endocrine neoplasm. J. Clin. Oncol. 29, e303–304 (2011).
Bloom, H. J. & Richardson, W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 11, 359–377 (1957).
Demicheli, R. et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann. Oncol. 16, 1449–1457 (2005).
Jones, R. G. & Thompson, C. B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 23, 537–548 (2009).
Chiosis, G. et al. Development of purine-scaffold small molecule inhibitors of Hsp90. Curr. Cancer Drug Targets 30, 371–376 (2003).
Recht, A. et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med. 334, 1356–1361 (1996).
Lewis, J. J., Leung, D., Espat, J., Woodruff, J. M. & Brennan, M. F. Effect of reresection in extremity soft tissue sarcoma. Ann. Surg. 231, 655–663 (2000).
Peggs, K. S., Quezada, S. A., Korman, A. J. & Allison, J. P. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr. Opin. Immunol. 18, 206–213 (2006).